Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (888) 282-7099 Click to print page  Print
Other options

view Contact Information


Contact Information for OB-822 & OBI-821 for Early-Stage Triple Negative Breast Cancer at High Risk for Recurrence

The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org

Moores UCSD Cancer Center, La Jolla, CA,  92093

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

Kaiser Permanente Medical Center, San Diego, CA,  92120

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

UCSF Helen Diller Family Comprehensive Cancer Centre, San Francisco, CA,  94158

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

Miami Cancer Institute, Miami, FL,  33176

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

University of Chicago Medical, Chicago, IL,  60637

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore, MD,  21201

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

Henry Ford Medical Center, Detroit, MI,  48202

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ,  08903

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

University of Texas Health Science Center at San Antonio, San Antonio, TX,  78229

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com

Northwest Medical Specialties, PLLC, Tacoma, WA,  98405

Principal Investigator: OBI Investigator Site
Contact person: OBI Pharma CT.gov Assistant
Phone:1-619-537-7821
Email: ClinicalTrials.gov-queries@obipharmausa.com